Alexander Stemer is an Infectious Disease physician affiliated with Indiana University Northwest. OpenAlex indexes 5 publications with 361 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10110 Don S Powers Drive
Ste 101d
Munster, IN 463214158
Telephone
219-922-3002Provider last certified this registry record 14 Apr 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
37.1%Statin7.4%Atorvastatin Calcium75%Simvastatin17%Rosuvastatin Calcium5%Pravastatin Sodium3%Part D<11 patientsBeta blocker6.4%Metoprolol Tartrate38%Carvedilol25%Metoprolol Succinate22%Propranolol Hcl6%Atenolol5%Kapspargo Sprinkle2%Labetalol Hcl2%Part D<11 patients+ 17 more classes in this area
Nervous system
24.1%SSRI8.3%Sertraline Hcl39%Escitalopram Oxalate28%Citalopram Hbr15%Trazodone Hcl14%Paroxetine Hcl4%Part D<11 patientsGabapentinoids3.2%Gabapentin100%Part D≥52 patients+ 14 more classes in this area
Metabolism & gastrointestinal
17.1%Proton pump inhibitor5.4%Pantoprazole Sodium72%Omeprazole28%Part D≥94 patientsPotassium supplement2.8%Potassium Chloride88%Klor-Con M2012%Part D<11 patients+ 17 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial
Carolina Digital Repository (University of North Carolina at Chapel Hill)
2021 - Bamlanivimab prevents COVID-19 morbidity and mortality in nursing-home setting
Topics in antiviral medicine
2021 - Prevention of Bloodstream Infections by Use of Daily Chlorhexidine Baths for Patients at a Long-Term Acute Care Hospital
Infection Control and Hospital Epidemiology
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”